FI883708A0 - Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja - Google Patents

Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja

Info

Publication number
FI883708A0
FI883708A0 FI883708A FI883708A FI883708A0 FI 883708 A0 FI883708 A0 FI 883708A0 FI 883708 A FI883708 A FI 883708A FI 883708 A FI883708 A FI 883708A FI 883708 A0 FI883708 A0 FI 883708A0
Authority
FI
Finland
Prior art keywords
protein
basic protein
basic
mixtures containing
isolating
Prior art date
Application number
FI883708A
Other languages
English (en)
Swedish (sv)
Other versions
FI91875B (fi
FI91875C (fi
FI883708A (fi
Inventor
Michael Doerschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI883708A0 publication Critical patent/FI883708A0/fi
Publication of FI883708A publication Critical patent/FI883708A/fi
Publication of FI91875B publication Critical patent/FI91875B/fi
Application granted granted Critical
Publication of FI91875C publication Critical patent/FI91875C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI883708A 1987-08-11 1988-08-09 Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja FI91875C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3726655 1987-08-11
DE19873726655 DE3726655A1 (de) 1987-08-11 1987-08-11 Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten

Publications (4)

Publication Number Publication Date
FI883708A0 true FI883708A0 (fi) 1988-08-09
FI883708A FI883708A (fi) 1989-02-12
FI91875B FI91875B (fi) 1994-05-13
FI91875C FI91875C (fi) 1994-08-25

Family

ID=6333496

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883708A FI91875C (fi) 1987-08-11 1988-08-09 Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja

Country Status (19)

Country Link
US (1) US5101013A (fi)
EP (1) EP0305760B1 (fi)
JP (1) JP2587867B2 (fi)
KR (1) KR0129539B1 (fi)
AT (1) ATE96447T1 (fi)
AU (1) AU609170B2 (fi)
CA (1) CA1340237C (fi)
DE (2) DE3726655A1 (fi)
DK (1) DK173502B1 (fi)
ES (1) ES2047007T3 (fi)
FI (1) FI91875C (fi)
HU (1) HU198218B (fi)
IE (1) IE61557B1 (fi)
IL (1) IL87385A (fi)
NO (1) NO175004C (fi)
NZ (1) NZ225746A (fi)
PH (1) PH26874A (fi)
PT (1) PT88230B (fi)
ZA (1) ZA885871B (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19652713C2 (de) * 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
KR100341297B1 (ko) * 1997-03-29 2002-11-16 주식회사종근당 재조합활성형프로인슐린의분리.정제방법
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
US6444788B1 (en) 1999-03-15 2002-09-03 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
WO2000055203A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
SE0300791D0 (sv) * 2003-03-20 2003-03-20 Amersham Biosciences Ab Use of ph-responsive polymers
KR20060106812A (ko) * 2003-08-21 2006-10-12 노보 노르디스크 에이/에스 라세미화 아미노산을 포함하는 폴리펩티드의 분리
EP1958879B1 (en) * 2005-08-04 2012-07-11 Toyo Seikan Kaisha, Ltd. Method for sterilization of plastic bottle
DK2349324T3 (en) 2008-10-17 2017-12-11 Sanofi Aventis Deutschland COMBINATION OF AN INSULIN AND A GLP-1 AGONIST
FR2947818B1 (fr) * 2009-07-09 2011-07-29 Inst Superieur Des Sciences Agronomiques Agroalimentaires Horticoles Et Du Paysage Agro Campus Ouest Utilisation d'un coproduit issu d'un procede d'extraction du lysozyme a partir de blanc d'oeuf, pour l'obtention d'au moins une proteine basique de blanc d'oeuf
KR101836070B1 (ko) 2009-11-13 2018-03-09 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ－１ 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN108079281A (zh) 2011-08-29 2018-05-29 赛诺菲-安万特德国有限公司 用于2型糖尿病患者中的血糖控制的药物组合
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP2748181B1 (en) 2011-09-30 2016-03-30 GE Healthcare BioProcess R&D AB Method for purification of cleaved pro-insulin
US10421795B2 (en) * 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2018147393A1 (ja) * 2017-02-10 2018-08-16 三菱ケミカル株式会社 ヒトインスリン精製用分離剤及びヒトインスリンの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629568C3 (de) * 1976-07-01 1981-09-10 Hoechst Ag, 6000 Frankfurt Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
NL7713966A (nl) * 1976-12-27 1978-06-29 Univ Minnesota Werkwijze voor het behandelen van insuline.
DK311477A (da) * 1977-07-08 1979-01-09 Leo Lab Fremgangsmaade ved fremstilling af rent insulin
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
DD247684A1 (de) * 1983-04-14 1987-07-15 Ulrich Krabiell Verfahren zur isolierung von insulinderivaten
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.
DE3440988A1 (de) * 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
DE3511269A1 (de) * 1985-04-12 1986-10-09 Veb Berlin-Chemie, Ddr 1199 Berlin Verfahren zur reinigung von insulin
JPS6379591A (ja) * 1986-09-22 1988-04-09 Mitsui Toatsu Chem Inc ｔＰＡの精製方法
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0365858B1 (en) * 1988-10-26 1994-11-30 American Cyanamid Company Process for reducing the aggregate content of growth hormone-like materials

Also Published As

Publication number Publication date
FI91875B (fi) 1994-05-13
IE882441L (en) 1989-02-11
DK447688D0 (da) 1988-08-10
HU198218B (en) 1989-08-28
NZ225746A (en) 1990-11-27
NO175004B (no) 1994-05-09
DK173502B1 (da) 2001-01-08
ZA885871B (en) 1989-04-26
AU609170B2 (en) 1991-04-26
DK447688A (da) 1989-02-12
NO883554L (no) 1989-02-13
IL87385A (en) 1993-08-18
JP2587867B2 (ja) 1997-03-05
FI91875C (fi) 1994-08-25
PH26874A (en) 1992-11-16
ES2047007T3 (es) 1994-02-16
IE61557B1 (en) 1994-11-16
FI883708A (fi) 1989-02-12
EP0305760A2 (de) 1989-03-08
JPS6486896A (en) 1989-03-31
HUT47958A (en) 1989-04-28
EP0305760B1 (de) 1993-10-27
CA1340237C (en) 1998-12-15
PT88230A (pt) 1989-06-30
ATE96447T1 (de) 1993-11-15
AU2059188A (en) 1989-02-16
DE3726655A1 (de) 1989-02-23
KR0129539B1 (ko) 1998-04-04
NO883554D0 (no) 1988-08-10
PT88230B (pt) 1995-03-01
DE3885214D1 (de) 1993-12-02
EP0305760A3 (en) 1990-06-06
NO175004C (no) 1994-08-17
KR890003799A (ko) 1989-04-18
US5101013A (en) 1992-03-31
IL87385A0 (en) 1989-01-31

Similar Documents

Publication Publication Date Title
FI883708A0 (fi) Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja
IL60184A0 (en) Process for the specific cleavage of protein sequences from proteins
DK0620709T3 (da) Fremgangsmåde til isolering af lactoferrin og lactoperoxidase fra mælk og mælkeprodukter
DK346783A (da) Triphenylimidazolyloxyalkansyrer og derivater deraf, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
FI880017A0 (fi) Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
ATE113960T1 (de) Proteingewinnung.
ZA917274B (en) Purification of proteins
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
Iwai et al. Histone fractions of protozoa: their correlation with mammalian histones
Yagi et al. Separation of Two Different Heavy Meromyosins Evidence for the Presence of Myosin Isozymes in Rabbit Skeletal Muscle
Bishop et al. Evidence for multiple molecular weight forms of the chick intestinal 1, 25-dihydroxyvitamin D3 receptor
NO173194C (no) Fremgangsmaate for fremstilling av proinsulin
ATE113991T1 (de) Verfahren zur reinigung hochreiner heparinase in grosser menge.
Bennett et al. Amino acid substitutions in mutant forms of histidinol dehydrogenase from Neurospora crassa
Thorpe et al. Some properties of myeloma proteins and their papain produced subunits
IJzerman et al. A refined method for the photoaffinity labelling of the nitrobenzylthioinosine-sensitive nucleoside transport protein: application to cell membranes of calf lung tissue
NEUHOFF et al. Micro-Analysis of Pure Deoxyribonucleic Acid-Dependent Ribonucleic Acid Polymerase from Escherichia coli, VI. Determination of the Amino Acid Composition
Takeshima et al. Ribosomal proteins of sea urchin eggs. I. Characterization of cytoplasmic ribosomal proteins
Koichi et al. Separation of Two Different Heavy Meromyosins
DK362288A (da) Homocyclostatin- og cyclostatinholdige peptider og farmaceutiske praeparater indeholdende disse
Kristoffersen et al. Identification of 20β-Hydroxy-pregn-4-ene-3-one in Luteal Tissue from Pregnant Whales
ES531495A0 (es) Procedimiento para preparar un hidrolizado proteinico
DK547486A (da) Peptider samt praeparater indeholdende disse

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH

PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH

MA Patent expired